PMID: 6387123Aug 1, 1984Paper

Survey of the human acetylator polymorphism in spontaneous disorders

Journal of Medical Genetics
D A Evans


There is ample evidence that the human acetylator phenotypes are associated with drug induced phenomena. It is principally the slow acetylators who exhibit toxic adverse effects because of their relative inability to detoxify the original drug compounds. In rare instances, however, it is the rapid acetylators who are at a disadvantage. In the matter of association of spontaneous disease with either acetylator phenotype, there are two groups of disorders to consider. First, disorders in which carcinogenic amines are known to be an aetiological factor. This is because these amines are substrates for the polymorphic N-acetyltransferase activity and hence there is a possible rational basis for searching for an association. Secondly, other disorders where searches for associations are based more on hunches. In the first group there is a definite statistical association between cancer of the bladder and the slow acetylator phenotype. In prevalence studies the slow phenotype is 39% more associated with bladder cancer than is the rapid phenotype. On the basis of the evidence now available it is not possible to say whether this association is because slow acetylators develop the disease more frequently or whether they survive longer. In...Continue Reading


Feb 19, 1979·European Journal of Clinical Pharmacology·P SchröderE Simonsen
Aug 1, 1978·European Journal of Clinical Investigation·R PlatzerR Preisig
Nov 1, 1975·Clinical Pharmacology and Therapeutics·K M Das, M A Eastwood
Jan 1, 1978·Australian and New Zealand Journal of Medicine·P Lee
Apr 1, 1977·Arthritis and Rheumatism·B FoadE V Hess
Jan 28, 1978·British Medical Journal·A W BurrowsJ G Taylor
Sep 1, 1978·British Journal of Clinical Pharmacology·E F MarshallM Roth
Apr 1, 1979·Annals of the Rheumatic Diseases·D H LawsonA Solomon
Jul 1, 1979·Canadian Journal of Physiology and Pharmacology·M M HodgkinW C Bailey
May 1, 1977·British Journal of Cancer·J G LavigneJ M Delage
Mar 1, 1978·Arthritis and Rheumatism·J VansantJ S Sergent
Jan 1, 1978·Oncology·L N BulovskayaM V Pavlova
Nov 4, 1978·British Medical Journal·H Olsen, J Mørland
Jan 1, 1979·Arthritis and Rheumatism·E Fishbein, D Alarcón-Segovia
Jan 1, 1979·British Journal of Clinical Pharmacology·R Arunkumar Shastri, K Krishnaswamy
Feb 1, 1976·Journal of Medical Genetics·A K Karim, D A Evans
Oct 1, 1975·British Journal of Clinical Pharmacology·A Fine, D J Sumner
Jul 30, 1977·British Medical Journal·E H McLarenP J Moorhead
Feb 24, 1975·JAMA : the Journal of the American Medical Association·N B Rabhan, W Minkin
Nov 1, 1975·The American Journal of Tropical Medicine and Hygiene·R H Gelber, R J Rees
Jul 1, 1975·The American Journal of Tropical Medicine and Hygiene·J H PetersA B Karat
Mar 17, 1973·Lancet·E C Johnstone, W Marsh
Aug 26, 1972·British Medical Journal·H Schröder
Mar 1, 1972·Journal of Medical Genetics·D A EvansJ M Vetters
Sep 15, 1972·Nature·G A EllardR J Rees
Jul 1, 1974·Arthritis and Rheumatism·J J Canoso, A S Cohen
Mar 1, 1972·Journal of Medical Genetics·L C Eze, D A Evans
May 1, 1972·Clinical Pharmacology and Therapeutics·R Zacest, J Koch-Weser
Jun 1, 1972·Journal of Medical Genetics·H Schröder, D A Evans
Nov 1, 1971·The British Journal of Psychiatry : the Journal of Mental Science·M A Schuckit, G Winokur
Dec 1, 1969·Journal of Medical Genetics·D A Evans
Jan 1, 1968·Clinical Pharmacology and Therapeutics·T A White, D A Evans
Jan 1, 1967·Scandinavian Journal of Gastroenterology·D A Evans
Jan 1, 1981·European Journal of Applied Physiology and Occupational Physiology·Y MinaireM J Jomain
Jan 1, 1981·European Journal of Clinical Pharmacology·M E SharpM A Brown
Feb 1, 1983·Journal of Medical Genetics·A K Azad KhanS C Truelove
Oct 1, 1983·Journal of Medical Genetics·D A EvansE J Whibley
Mar 27, 1982·British Medical Journal·R Mansilla-TinocoJ M Jones
Jan 1, 1983·The British Journal of Dermatology·A F SwainL Fry
Feb 1, 1982·British Journal of Clinical Pharmacology·H Olsen, J Mørland
Jun 1, 1982·Diabetologia·G M ShenfieldR Tjokresetio
Oct 1, 1982·Human Toxicology·K W WoodhouseM D Rawlins
Jan 1, 1981·Archives of Dermatological Research·J M LaderoS Chinarro
May 1, 1980·Arthritis and Rheumatism·M M ReidenbergW C Robbins
May 1, 1956·Annals of Human Genetics·J B HALDANE
Jul 1, 1965·Clinical Pharmacology and Therapeutics·D A EvansR T PRATT
Aug 1, 1976·British Journal of Clinical Pharmacology·B CaddyE C Johnstone
Dec 1, 1976·British Journal of Clinical Pharmacology·W CampbellT D Lawrie


Jan 1, 1988·European Journal of Clinical Pharmacology·J M LaderoA Robledo
Jan 1, 1989·European Journal of Clinical Pharmacology·J M LaderoJ J Muñoz
Jan 1, 1989·European Journal of Clinical Pharmacology·C StollJ L Imbs
Jan 1, 1995·International Archives of Occupational and Environmental Health·M RiffelmannK Norpoth
Feb 1, 1991·Irish Journal of Medical Science·P HollandJ Feely
Jan 1, 1989·Pharmacology & Therapeutics·D A Evans
Dec 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M BlumU A Meyer
Oct 1, 1994·Diabetic Medicine : a Journal of the British Diabetic Association·S NeugebauerK Kurokawa
Jan 1, 1990·Progress in Liver Diseases·U A MeyerM Blum
Dec 1, 1985·Journal of Medical Genetics·D A EvansG Alvarez
Nov 1, 1992·Arthritis and Rheumatism·S ShiokawaM Nobunaga
Oct 15, 1986·Experientia·D P Agarwal, H W Goedde
May 30, 2009·Cancer Investigation·Shaheenah Dawood, Brian Leyland-Jones
Jun 7, 2011·Seminars in Perinatology·Mark G Bartlett, Glenn R Gourley
Jan 1, 1986·Journal of Chronic Diseases·M J KhouryB H Cohen
Jun 1, 1988·Acta Psychiatrica Scandinavica·L Träskman-BendzL Brown
Oct 1, 1986·British Journal of Clinical Pharmacology·D SuhardjonoG M Shenfield
Jun 1, 1987·British Journal of Clinical Pharmacology·P A PhilipP Crome
Apr 1, 1988·British Journal of Clinical Pharmacology·Y Horai, T Ishizaki
Jun 28, 1991·Biochemical and Biophysical Research Communications·T Ebisawa, T Deguchi
Apr 1, 1995·Biopharmaceutics & Drug Disposition·K Y HsuY Ho
May 7, 2002·The Pharmacogenomics Journal·N J ButcherR F Minchin
Feb 23, 2008·Annals of Medicine·Ribhi HazinArash Kimyai-Asadi
Jan 1, 1990·Fundamental & Clinical Pharmacology·U A Meyer
Feb 1, 1994·Acta Neurologica Scandinavica·J M LaderoJ Benítez

Related Concepts

Malignant Neoplasm of Urinary Bladder
Mammary Neoplasms, Human
Diabetes Mellitus
Pharmaceutical Preparations
Gilbert Disease (Disorder)
Lupus Erythematosus, Systemic
Genetic Polymorphism

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Torsion Dystonia

Torsion dystonia is a movement disorder characterized by loss of control of voluntary movements appearing as sustained muscle contractions and/or abnormal postures. Here is the latest research.

Generating Insulin-Secreting Cells

Reprogramming cells or using induced pluripotent stem cells to generate insulin-secreting cells has significant therapeutic implications for diabetics. Here is the latest research on generation of insulin-secreting cells.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.

Epigenome Editing

Epigenome editing is the directed modification of epigenetic marks on chromatin at specified loci. This tool has many applications in research as well as in the clinic. Find the latest research on epigenome editing here.